Get started
Work

Safety and Efficacy of Shockwave Therapy for Myogenous Temporomandibular Disorders: Early Post-Treatment Results

Year: 2025
Type: article
Abstract: INTRODUCTION AND AIMS: To evaluate the early post-treatment safety and efficacy of extracorporeal shockwave therapy (ESWT) in the management of myogenous temporomandibular disorder (M-TMD). METHODS: A randomized clinical trial following the CONSORT 2010 statement was conducted. Patients with M-TMD were recruited and randomly assigned in a 1:1 ratio into two groups: the ESWT Group and the Placebo Group. Three sessions of therapy were delivered. Pain score and jaw function were measured at pre-treatment baseline (T0), 1 week after each therapy session (T1, T2, T3), and 6 weeks (T4) and 3 months (T5) after the last session. Outcomes in pain score and jaw function were compared between the 2 groups. RESULTS: Sixty-four patients (13 males, 51 females) with M-TMD were recruited with 33 patients in the ESWT group and 31 in the Placebo group. There were no differences between the 2 groups in the baseline pain score and jaw functions. The pain score in the ESWT group was remarkably lower than the Placebo group at the subsequent time points T1-T4. The overall mean decrease in pain in the ESWT group was 2.6 (P < .001). No significant difference was found in the jaw functions between the two groups. No significant complications or adverse effects have been reported. CONCLUSION: Extracorporeal shockwave could be a safe treatment option that provides more rapid and significant pain reduction. CLINICAL RELEVANCE: ESWT could be presented as an effective alternative treatment option in the management of M-TMD.
DOI: 10.1016/j.identj.2025.103923
Authors: Ka Wing Law, Andy Wai Kan Yeung, Yiu Yan Leung
Language: English
Open Access status: gold
Estimated APC paid: $2,550
OpenAlex ID: W4414533213
FWCI: 2.977
Cites: 56
Cited by: 3
Related to: